HomeCompareGNTTF vs SCHD

GNTTF vs SCHD: Dividend Comparison 2026

GNTTF yields 20000.00% · SCHD yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNTTF wins by $52481917574412746752.00M in total portfolio value
10 years
GNTTF
GNTTF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full GNTTF calculator →
SCHD
Schwab U.S. Dividend Equity ETF
● Live price
3.44%
Share price
$30.68
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$422.61
Full SCHD calculator →

Portfolio growth — GNTTF vs SCHD

📍 GNTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNTTFSCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNTTF + SCHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNTTF pays
SCHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNTTF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
SCHD
Annual income on $10K today (after 15% tax)
$292.49/yr
After 10yr DRIP, annual income (after tax)
$359.22/yr
At 15% tax rate, GNTTF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNTTF + SCHD for your $10,000?

GNTTF: 50%SCHD: 50%
100% SCHD50/50100% GNTTF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNTTF buys
0
SCHD buys
0
No recent congressional trades found for GNTTF or SCHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNTTFSCHD
Forward yield20000.00%3.44%
Annual dividend / share$2.00$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$52481917574412746752.00M$29.0K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00$422.61
Total dividends collected$52448189483771600896.00M$3.9K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: GNTTF vs SCHD ($10,000, DRIP)

YearGNTTF PortfolioGNTTF Income/yrSCHD PortfolioSCHD Income/yrGap
1← crossover$2,010,700$2,000,000.00$11,224$344.10+$2.00MGNTTF
2$377,983,225$375,831,775.70$12,567$354.98+$377.97MGNTTF
3$66,433,479,469$66,029,037,418.28$14,038$365.30+$66433.47MGNTTF
4$10,916,985,471,987$10,845,901,648,955.73$15,648$375.06+$10916985.46MGNTTF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$17,410$384.27+$1677384363.75MGNTTF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$19,335$392.95+$240985175079.12MGNTTF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$21,437$401.10+$32373573631143.68MGNTTF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$23,733$408.75+$4066766648320630.00MGNTTF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$26,237$415.91+$477730483406513344.00MGNTTF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$28,968$422.61+$52481917574412746752.00MGNTTF

GNTTF vs SCHD: Complete Analysis 2026

GNTTFStock

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.

Full GNTTF Calculator →

SCHDETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →
📬

Get this GNTTF vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNTTF vs JEPIGNTTF vs OGNTTF vs KOGNTTF vs MAINGNTTF vs VYMGNTTF vs DGROGNTTF vs VIGGNTTF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.